T2 Biosystems CS (TTOO)

$0.08 -0.06 (-41.49%)
Market Cap 4.09M
Revenue (ttm) 7.19M
Net Income (ttm) -50.08M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -696.52%
Debt to Equity Ratio 0.00
Volume 4,010,500
Avg Vol 1,494,488
Day's Range N/A - N/A
Shares Out 21.04M
Stochastic %K 5%
Beta 0.35
Analysts Hold
Price Target $5.00

Company Profile

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 761 4646
Address:
101 Hartwell Avenue, Lexington, United States
Novice_2026
Novice_2026 Aug. 19 at 4:26 PM
$TTOO No new SEC info since 2025
1 · Reply
Fair_Trader42
Fair_Trader42 Aug. 19 at 4:25 PM
$TTOO Fortunately Minority Shareholder Rights enjoy the BEST protections under Delaware Law: a tiny company with one President might try to make an under the table deal and sell IP before bankruptcy, but there's too many lawyers with too many large companies here for anything but an orderly end game.
2 · Reply
Novice_2026
Novice_2026 Aug. 19 at 3:25 PM
$TTOO Where the Two Views Converge Ultimately, this comes down to two completely different ways of evaluating the endgame: The Procedural View: Strategic acquirers will act in their own cold self-interest—using T2’s liquidating status to pay the bare minimum required to satisfy senior debt (CRG) and capture the IP as cheaply as possible. The Strategic Disruption View: The necessity for rapid, direct-from-blood detection is so undeniable that a buyer will pay a massive, top-of-market strategic price to lock out competitors and control the future of diagnostics. Whether traditional financial analysts are "blinded by antiquated thinking" or simply following the strict rules of corporate debt, the ultimate outcome will depend on whether a bidder decides to play by the standard distress playbook or rewrite it entirely to secure the technology.
0 · Reply
tcamp923
tcamp923 Aug. 19 at 2:24 PM
$TTOO sup
1 · Reply
jeni1988
jeni1988 Aug. 19 at 1:43 PM
$TTOO Moderna makes 100% , we need 1000000% 😂😂😂😂😂😂
0 · Reply
Novice_2026
Novice_2026 Aug. 19 at 1:04 PM
$TTOO https://investors.t2biosystems.com/
1 · Reply
spinooch
spinooch Aug. 19 at 12:16 PM
$TTOO anyone remember the "best investment in market history" guy?
0 · Reply
Novice_2026
Novice_2026 Aug. 19 at 5:20 AM
$TTOO @Fair_Trader42 @INCOGNITOINVESTS DD req'd. asked AI about Merck and Moderna cancer vaccine and direct from blood diagnostics... here is a snip of Gemini's reply....
2 · Reply
BadatStocks2023
BadatStocks2023 Aug. 19 at 2:17 AM
$TTOO do not buy into this scam company, steer clear with a 100 ft pole. Anyone trying to sell you this is a bag holding moron.
1 · Reply
Fair_Trader42
Fair_Trader42 Aug. 19 at 2:12 AM
$TTOO During the Klondike Gold Rush, the guys that really made the money were those selling the Picks & Shovels. I gotta believe this is a great frik’n Shovel !
4 · Reply
Latest News on TTOO
No data available.
Novice_2026
Novice_2026 Aug. 19 at 4:26 PM
$TTOO No new SEC info since 2025
1 · Reply
Fair_Trader42
Fair_Trader42 Aug. 19 at 4:25 PM
$TTOO Fortunately Minority Shareholder Rights enjoy the BEST protections under Delaware Law: a tiny company with one President might try to make an under the table deal and sell IP before bankruptcy, but there's too many lawyers with too many large companies here for anything but an orderly end game.
2 · Reply
Novice_2026
Novice_2026 Aug. 19 at 3:25 PM
$TTOO Where the Two Views Converge Ultimately, this comes down to two completely different ways of evaluating the endgame: The Procedural View: Strategic acquirers will act in their own cold self-interest—using T2’s liquidating status to pay the bare minimum required to satisfy senior debt (CRG) and capture the IP as cheaply as possible. The Strategic Disruption View: The necessity for rapid, direct-from-blood detection is so undeniable that a buyer will pay a massive, top-of-market strategic price to lock out competitors and control the future of diagnostics. Whether traditional financial analysts are "blinded by antiquated thinking" or simply following the strict rules of corporate debt, the ultimate outcome will depend on whether a bidder decides to play by the standard distress playbook or rewrite it entirely to secure the technology.
0 · Reply
tcamp923
tcamp923 Aug. 19 at 2:24 PM
$TTOO sup
1 · Reply
jeni1988
jeni1988 Aug. 19 at 1:43 PM
$TTOO Moderna makes 100% , we need 1000000% 😂😂😂😂😂😂
0 · Reply
Novice_2026
Novice_2026 Aug. 19 at 1:04 PM
$TTOO https://investors.t2biosystems.com/
1 · Reply
spinooch
spinooch Aug. 19 at 12:16 PM
$TTOO anyone remember the "best investment in market history" guy?
0 · Reply
Novice_2026
Novice_2026 Aug. 19 at 5:20 AM
$TTOO @Fair_Trader42 @INCOGNITOINVESTS DD req'd. asked AI about Merck and Moderna cancer vaccine and direct from blood diagnostics... here is a snip of Gemini's reply....
2 · Reply
BadatStocks2023
BadatStocks2023 Aug. 19 at 2:17 AM
$TTOO do not buy into this scam company, steer clear with a 100 ft pole. Anyone trying to sell you this is a bag holding moron.
1 · Reply
Fair_Trader42
Fair_Trader42 Aug. 19 at 2:12 AM
$TTOO During the Klondike Gold Rush, the guys that really made the money were those selling the Picks & Shovels. I gotta believe this is a great frik’n Shovel !
4 · Reply
Novice_2026
Novice_2026 Aug. 18 at 2:39 PM
$TTOO AI Info DD req'd. to verify. FYI: platforms like the T2Lyme panel become less practical and significantly less effective as time passes, completely losing their edge to standard serology (antibody testing) Efficiency Shifts (First Few Weeks): Direct DNA detection shines. Standard serology (ELISA/Western Blot or Modified Two-Tier Testing) suffers from a diagnostic blind spot during the first 2–4 weeks because the body takes time to mount an antibody response . In this window, direct DNA detection offers high specificity before antibodies mature. (T2 importance) Patient avoids long term effects (After a Few Months): The dynamic reverses. Borrelia burgdorferi does not linger in high volumes in the bloodstream. It rapidly leaves the vascular space to hide in deep tissues—such as (joints), (nerves), and skin. Transient (bacteria circulating in whole blood) drops off significantly. DNA assays face severe target-scarcity issues, high false-negative rates in late-stages.
0 · Reply
Novice_2026
Novice_2026 Aug. 18 at 4:46 AM
$TTOO search... Ticks - The Real Vampires | Full Documentary 50 mins long very informative
0 · Reply
thedonutman
thedonutman Aug. 18 at 1:12 AM
$TTOO Good article: https://www.nbcnews.com/health/health-news/ticks-lyme-fever-diseases-north-carolina-threat-south-cdc-rcna592307
1 · Reply
911AXX
911AXX Aug. 17 at 7:56 PM
$TTOO crap
1 · Reply
StockDreamin
StockDreamin Aug. 17 at 2:42 PM
$TTOO lol! The joke that keeps going!
0 · Reply
Zefram
Zefram Aug. 16 at 5:39 AM
$TTOO thousands of opportunity in the market every day, but because you decided not to do the due diligence before torching your money... you've been stuck in a dead company for months.. years... speculating on a buy out that has zero evidence is happening.. other than the hopium thought of "if there's silence.. it means they're working on something...."... when has that ever been the case with this company? isnt it more likely that there's silence because like every real signal and every person that would know.... says it's a dead company? it's funny that you think the idea based on real verified information is wrong.... and that your hopes and conspiracy theories must be the what is happening... such a noob psychological trap... loosing money messes up your brains.
0 · Reply
Zefram
Zefram Aug. 15 at 8:34 PM
$TTOO wait.. you got prompted? oooooh that makes so much sense now. YOU'RE the dumb LLM chatbot. should have been obvious.. a normal person couldnt be that dumb.
0 · Reply
Novice_2026
Novice_2026 Aug. 15 at 8:14 PM
$TTOO @_Chucky your last Post hitting the 18th month point was interesting. Prompted me to ask AI to follow up.
4 · Reply
BobbyJay55
BobbyJay55 Aug. 15 at 12:00 PM
$TTOO
0 · Reply
Zefram
Zefram Aug. 15 at 3:21 AM
$TTOO dont worry guys.. ttoo must be 26th.
0 · Reply
bjay11
bjay11 Aug. 14 at 11:57 PM
$TTOO Another recent article tagging T2 Biosystems https://www.linkedin.com/posts/rapid-antimicrobial-susceptibility-share-7493893369383940096-wJEt/?utm_source=share&utm_medium=member_android&rcm=ACoAAA1Of_wB2xlDS1GKIlyvQgqxCgWF0yK9kxY
1 · Reply
Zefram
Zefram Aug. 14 at 7:04 PM
$TTOO LOL guys.. NOW??? 18 months after they closed and said there were no buyers... NOW is the time they'll start announcing stuff.. we'll be here in 2032... and some of you guys will still think there's a buyout coming.. come on, bros... you gonna extend the deadlines and timelines until the patents expire right? it's over, boys.
0 · Reply